Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-06 Purchase | 2021-12-07 08:30 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher CFO | 5,000 | $0.9403 | $4,702 | 151,500 (Direct) | View |
| 2021-11-19 Purchase | 2021-11-22 08:47 am | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher CFO | 4,500 | $1.1537 | $5,192 | 146,500 (Direct) | View |
| 2020-08-24 Purchase | 2020-08-25 7:11 pm | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher CFO | 142,000 | $2.04 | $289,680 | 142,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-28 Option Award | 2022-04-29 5:12 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher CFO | 250,000 | $0 | 681,000 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 5:11 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Climaco John M CEO | 600,000 | $0 | 1,349,500 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-14 09:40 am | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher CFO | 33,000 | $0.31 | 184,500 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 2:34 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director | 11,100 | $0.2968 | 11,100 (Direct) | View |
| 2022-03-08 Option Award | 2022-03-09 2:34 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 3,750 | $0.268 | 3,750 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-08 08:30 am | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Climaco John M CEO | 35,000 | $0.281 | 940,298 (Direct) | View |
| 2020-05-05 Other | 2022-01-25 4:05 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Priebe Waldemar 10% Owner | 1,495,867 | $0 | 9,029,000 (Indirect) | View |
| 2021-11-16 Option Award | 2021-11-18 8:07 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Climaco John M CEO | 5,000 | $1.28 | 905,298 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-16 5:00 pm | N/A 2031-07-15 | CNS Pharmaceuticals Inc. | CNSP | Andraczke Andrzej Director | 32,000 | $0 | 178,559 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-16 5:00 pm | N/A 2031-07-15 | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 32,000 | $0 | 178,559 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-16 5:00 pm | N/A 2031-07-15 | CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director | 32,000 | $0 | 178,559 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-16 5:00 pm | N/A 2031-07-15 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 32,000 | $0 | 178,559 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 5:00 pm | N/A 2031-02-05 | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher CFO | 131,000 | $0 | 431,000 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 5:00 pm | N/A 2031-02-05 | CNS Pharmaceuticals Inc. | CNSP | Climaco John M CEO | 310,000 | $0 | 749,500 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-16 5:23 pm | N/A 2030-06-12 | CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director | 46,559 | $0 | 146,559 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-16 5:23 pm | N/A 2030-06-12 | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 46,559 | $0 | 146,559 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-16 5:23 pm | N/A 2030-06-12 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 46,559 | $0 | 146,559 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-16 5:22 pm | N/A 2030-06-12 | CNS Pharmaceuticals Inc. | CNSP | Andraczke Andrzej Director | 46,559 | $0 | 146,559 (Direct) | View |
| 2019-11-13 Option Award | 2019-11-13 5:12 pm | N/A 2029-11-13 | CNS Pharmaceuticals Inc. | CNSP | Downs Christopher CFO | 300,000 | $0 | 300,000 (Direct) | View |
| 2019-11-07 Ownership | 2019-11-08 5:31 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Priebe Waldemar 10% Owner | 0 | $0 | 9,029,000 (Indirect) | View |
| 2019-11-07 Ownership | 2019-11-08 5:31 pm | N/A 2028-06-25 | CNS Pharmaceuticals Inc. | CNSP | Keyes Jeffry R. Director | 0 | $0 | 100,000 (Direct) | View |
| 2019-11-07 Ownership | 2019-11-08 5:30 pm | N/A 2027-11-08 | CNS Pharmaceuticals Inc. | CNSP | Gumulka Jerzy Director | 0 | $0 | 100,000 (Direct) | View |
| 2019-11-07 Ownership | 2019-11-08 5:26 pm | N/A 2028-07-09 | CNS Pharmaceuticals Inc. | CNSP | Evans Carl Anthony Director | 0 | $0 | 100,000 (Direct) | View |
| 2019-11-07 Ownership | 2019-11-08 5:25 pm | N/A N/A | CNS Pharmaceuticals Inc. | CNSP | Climaco John M CEO | 0 | $0 | 1,339,500 (Direct) | View |
| 2019-11-07 Ownership | 2019-11-08 5:24 pm | N/A 2028-07-09 | CNS Pharmaceuticals Inc. | CNSP | Andraczke Andrzej Director | 0 | $0 | 100,000 (Direct) | View |